Brainstorm cell therapeutics announces third quarter 2021 financial results and provides a corporate update

New york, nov. 15, 2021 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, today announced financial results for the quarter ended september 30, 2021, and provided a corporate update. "we made strong progress towards our goal of advancing nurown in als and ms over the past months," said chaim lebovits, chief executive officer, brainstorm cell therapeutics.
BCLI Ratings Summary
BCLI Quant Ranking